---
title: Deglycyrrhizinated Licorice (DGL) in Promoting Gastric Mucosal Health
description: DGL supports gastric mucosal health, and one trial found it reduced ulcer size by 78% versus 34% with placebo.
image: https://www.casi.org/hubfs/casi/featured/adobestock_241405476.jpeg
---

An **educational publication of Designs for Health**

[For Practitioners →](https://www.designsforhealth.com)

[![casilogoresize2-2](https://www.casi.org/hubfs/casilogoresize2-2.png)](https://www.casi.org/)

[Home](https://www.casi.org/) [Science Update](https://www.casi.org/articles/tag/science-update) [Research & Education](https://www.casi.org/articles/tag/research-education) [Archive](https://www.casi.org/articles/all)

Search articles

Search

Research & Education

# Deglycyrrhizinated Licorice (DGL) in Promoting Gastric Mucosal Health

DM Danielle C. Male, MS, CNS, LDN Dec 22, 2022

![Deglycyrrhizinated Licorice (DGL) in Promoting Gastric Mucosal Health](https://www.casi.org/hs-fs/hubfs/casi/featured/adobestock_241405476.jpeg?width=960)

The [gastrointestinal mucosa](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104804/) plays a pivotal role in the immune system, GI system, and overall health. The GI mucosa supports intestinal barrier function, regulates healthy immune responses, and wards off potentially harmful antigens and microorganisms. In the stomach, the mucosa serves as a protective coating from hydrochloric acid. Poor diet, alcohol consumption, smoking, stress, and certain medications may [negatively impact GI mucosal health](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104804/). Compromised GI mucosa may be associated with a broad range of GI disorders (e.g., [peptic ulcers](https://www.ncbi.nlm.nih.gov/books/NBK534792/), [celiac disease, inflammatory bowel disease](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104804/)) or other chronic conditions (e.g., [allergies](https://pubmed.ncbi.nlm.nih.gov/30366757/), [obesity, chronic liver disease](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104804/)). 

Deglycyrrhizinated licorice (DGL) is a licorice extract from the [ayurvedic herb *Glycyrrhiza glabra*](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703329/) that has been shown to support [GI mucosal health, promote healthy microbial environments, and potentially have anti-inflammatory and antioxidant properties](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348626/). The medicinal use of licorice dates back several thousand years in both Western and Eastern cultures. DGL is “[deglycyrrhizinated](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348626/)” (glycyrrhizin removed) due to the potential [adverse side effects](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427648/) associated with the glycyrrhizin molecule. 

Animal studies reveal that DGL supports GI mucosal health in multiple ways. It increases [prostaglandin synthesis](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673944/), the [blood supply](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348626/) to damaged mucosa, the number of [mucus-producing cells](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348626/), the amount of [mucus the cells produce](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348626/), and the [lifespan of intestinal cells](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348626/). Owing to these benefits, a human study administering [GutGard](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123991/)® (a patented form of DGL) concluded that DGL might support those with [functional dyspepsia](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123991/) and is generally well tolerated. Many human clinical studies conclude that DGL may support individuals with [gastric ulcers](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348626/). 

In one [randomized controlled trial](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348626/), 33 patients with gastric ulcers were given a placebo or 760 mg of DGL three times a day for one month. The individuals receiving DGL experienced significantly greater reductions in ulcer size (78%) compared to the placebo group (34%). Furthermore, 44% of the individuals receiving DGL displayed complete ulcer healing compared to 6% in the placebo group. 

[*Helicobacter Pylori*](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892500/) (*H. Pylori*)is a bacterial infection estimated to affect [half of the world’s population](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892500/) and is associated with [GI mucosal barrier damage](https://www.ncbi.nlm.nih.gov/books/NBK534792/). The [flavonoids](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348626/) in DGL may be clinically beneficial in those with *H. Pylori* by supporting [mucosal health](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427648/), promoting [antimicrobial](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427648/) properties, and potentially attenuating [*H. Pylori* gastric mucosal adhesion](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427648/). 

DGL in GutGard® has been shown to help attenuate *H. Pylori* infection in [animal models](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892500/) and [human studies](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623263/). In a [randomized, double-blind, placebo-controlled study](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623263/), participants diagnosed with *H. Pylori* infection were randomly assigned to receive a placebo (n = 52) or 150 mg of GutGard® daily (n = 55) for 60 days. On the 60th day, more than half of the subjects (56%) receiving GutGard® had negative *H. Pylori* results, compared to only 4% of subjects receiving the placebo. 

DGL is a well-established herb that supports the gastrointestinal system. DGL may help maintain a healthy gastric mucosa and promote a healthy microbial balance in the stomach. 

On this page

Share

[LinkedIn](https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fwww.casi.org%2Farticles%2Fdeglycyrrhizinated-licorice-in-promoting-gastric-mucosal-health) [X](https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.casi.org%2Farticles%2Fdeglycyrrhizinated-licorice-in-promoting-gastric-mucosal-health&text=Deglycyrrhizinated+Licorice+%28DGL%29+in+Promoting+Gastric+Mucosal+Health) [Email](mailto:?subject=Deglycyrrhizinated%20Licorice%20%28DGL%29%20in%20Promoting%20Gastric%20Mucosal%20Health&body=https%3A%2F%2Fwww.casi.org%2Farticles%2Fdeglycyrrhizinated-licorice-in-promoting-gastric-mucosal-health)

DM

### Danielle C. Male, MS, CNS, LDN

Clinical Application

## Clinical Considerations in Practice

 In clinical practice, practitioners considering the topics discussed above may also weigh nutrient form, delivery and formulation, alongside individual patient variability.

### Practitioner Formulation Example

![DGL Synergy™](https://cdn.sanity.io/images/lemtscrs/production-www/faf87c67b245c5c8cd9f5876c32a541592e9c900-2000x2000.png?w=128&h=128&fit=max&auto=format)

DGL Synergy™

DGL with calcium and glycine · Tablets

[Explore Formulations →](https://www.designsforhealth.com/products/dgl-synergy)

## Continue your research

#### [Research & Education Magnesium Glycinate Chelate Buffered: A Smart Approach to Magnesium Supplementation May 21, 2026](https://www.casi.org/articles/magnesium-glycinate-chelate-buffered-a-smart-approach-to-magnesium-supplementation)

#### [Science Update A Case Report on a Functional GI Testing Protocol in a 35-Year-Old Female with Gastrointestinal and Joint Discomfort May 07, 2026](https://www.casi.org/articles/a-case-report-on-a-functional-gi-testing-protocol-in-a-35-year-old-female-with-gastrointestinal-and-joint-discomfort)

#### [Science Update A Case Report on Anaerostipes caccae Supplementation in a 47-Year-Old Female with Long-Term Food Intolerances Apr 09, 2026](https://www.casi.org/articles/a-case-report-on-anaerostipes-caccae-supplementation-in-a-47-year-old-female-with-long-term-food-intolerances)

#### [Research & Education Sleep Support Beyond Melatonin: Targeting the Gut–Brain Axis with L. gasseri CP2305 Feb 23, 2026](https://www.casi.org/articles/sleep-support-gut-brain-axis-l-gasseri-cp2305)

![casilogoresize2-2](https://www.casi.org/hubfs/casilogoresize2-2.png)

An educational publication of [**Designs for Health**](https://www.designsforhealth.com). Peer-reviewed nutrition science, free for everyone.

#### Sections

- [Science Update](https://www.casi.org/articles/tag/science-update)
- [Research & Education](https://www.casi.org/articles/tag/research-education)

#### Terms & Conditions

- [Privacy Notice](https://www.designsforhealth.com/privacy-notice)
- [Terms of Use](https://www.designsforhealth.com/terms-of-use)

CASI.org © 2026 All rights reserved

 Do not sell my personal information 

Built with care · Peer-reviewed since 1996

```json
{
  "@context" : "https://schema.org",
  "@type" : "BreadcrumbList",
  "itemListElement" : [ {
    "@type" : "ListItem",
    "item" : "https://www.casi.org/",
    "name" : "Home",
    "position" : 1
  }, {
    "@type" : "ListItem",
    "item" : "https://www.casi.org/articles",
    "name" : "The CASI Library",
    "position" : 2
  }, {
    "@type" : "ListItem",
    "name" : "Deglycyrrhizinated Licorice (DGL) in Promoting Gastric Mucosal Health",
    "position" : 3
  } ]
}
```

```json
{
  "@context" : "https://schema.org",
  "@id" : "https://www.casi.org/articles/deglycyrrhizinated-licorice-in-promoting-gastric-mucosal-health",
  "@type" : "WebPage",
  "dateModified" : "2026-09-17"
}
```

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Danielle C. Male, MS, CNS, LDN",
    "url" : "https://www.casi.org/articles/author/danielle-c-male-ms-cns-ldn"
  },
  "datePublished" : "2022-12-22T05:00:00.000Z",
  "headline" : "Deglycyrrhizinated Licorice (DGL) in Promoting Gastric Mucosal Health",
  "image" : [ "https://www.casi.org/hubfs/casi/featured/adobestock_241405476.jpeg" ],
  "mainEntityOfPage" : {
    "@id" : "https://www.casi.org/articles/deglycyrrhizinated-licorice-in-promoting-gastric-mucosal-health",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://www.casi.org/hubfs/casilogoresize2-2.png"
    },
    "name" : "CASI.org"
  }
}
```